{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:49:07Z","timestamp":1791355747839,"version":"4.3.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T00:00:00Z","timestamp":1305763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2334-11-134","type":"journal-article","created":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T19:01:48Z","timestamp":1305831708000},"source":"Crossref","is-referenced-by-count":175,"title":["Systematic review of influenza resistance to the neuraminidase inhibitors"],"prefix":"10.1186","volume":"11","author":[{"given":"Kristian","family":"Thorlund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahany","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Boivin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,19]]},"reference":[{"key":"1492_CR1","unstructured":"Influenza infection. 2010, [ http:\/\/www.who.int\/mediacentre\/factsheets\/fs211\/en\/index.html ]"},{"key":"1492_CR2","unstructured":"Influenza: Pathogens and disease. 2010, [ http:\/\/www.who.int\/biologicals\/areas\/vaccines\/influenza\/influenza_pathogens_disease\/en\/index.html ]"},{"key":"1492_CR3","unstructured":"Influenza viruses. 2010, [ http:\/\/www.cdc.gov\/flu\/avian\/gen-info\/flu-viruses.htm ]"},{"key":"1492_CR4","unstructured":"CDC Resources for Pandemic Flu. 2010, [ http:\/\/www.cdc.gov\/flu\/pandemic ]"},{"key":"1492_CR5","unstructured":"ACIP Recommendations: Introduction and Biology of Influenza. 2010, [ http:\/\/www.cdc.gov\/flu\/professionals\/acip\/background.htm ]"},{"key":"1492_CR6","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1586\/14787210.4.5.795","volume":"4","author":"AC Hurt","year":"2006","unstructured":"Hurt AC, HO HT, Barr I: Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors. Expert Rev Anti Infect Ther. 2006, 4: 795-805. 10.1586\/14787210.4.5.795.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1492_CR7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1517\/14740330902840519","volume":"8","author":"P Schirmer","year":"2009","unstructured":"Schirmer P, Holodniy M: Oseltamivir for treatment and prophylaxis of influenza infection. Expert Opin Drug Saf. 2009, 8: 357-371. 10.1517\/14740330902840519.","journal-title":"Expert Opin Drug Saf"},{"key":"1492_CR8","doi-asserted-by":"crossref","unstructured":"Jefferson T, Jones MA, Doshi P, Del Mar CB, Dooley L, Foxlee R: Neuraminidase inhibitors for preventing and treating influenza in health adults. Cochrane Database of Systematic Reviews. 2010, 2","DOI":"10.1002\/14651858.CD001265.pub3"},{"key":"1492_CR9","unstructured":"Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. 2010, [ http:\/\/www.cdc.gov\/H1N1flu\/recommendations.htm ]"},{"key":"1492_CR10","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1128\/AAC.01311-09","volume":"54","author":"S Kubo","year":"2010","unstructured":"Kubo S, Tomozawa T, Kubata M, Tokumitau A, Yamashita M: Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration. Antimicrob Agents Chemother. 2010, 54: 1256-1264. 10.1128\/AAC.01311-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"1492_CR11","first-page":"71","volume":"21","author":"M Yamashita","year":"2011","unstructured":"Yamashita M: Laninamivir and its prodrug, CS-8958: long-acting neuraminidase inhibitors for the treatment of influenza. Antimicrob Agents Chemother. 2011, 21: 71-84.","journal-title":"Antimicrob Agents Chemother"},{"key":"1492_CR12","first-page":"57","volume":"32","author":"AC Hurt","year":"2008","unstructured":"Hurt AC, Barr IG: Influenza viruses with reduced sensitivity to the NA inhibitor drugs in untreated young children. Communicable Diseases Intelligence. 2008, 32: 57-62.","journal-title":"Communicable Diseases Intelligence"},{"key":"1492_CR13","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1097\/INF.0b013e318168b739","volume":"27","author":"AS Monto","year":"2006","unstructured":"Monto AS, McKimm-Breschken JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG, et al: Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Pediatric Infectious Diseases Journal. 2006, 27: S110-S112.","journal-title":"Pediatric Infectious Diseases Journal"},{"key":"1492_CR14","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","volume":"364","author":"M Kiso","year":"2004","unstructured":"Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Hayden FG, Sugaya N, Kawaoka Y: Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet. 2004, 364: 759-765. 10.1016\/S0140-6736(04)16934-1.","journal-title":"Lancet"},{"key":"1492_CR15","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1086\/314440","volume":"178","author":"LV Gubareva","year":"1998","unstructured":"Gubareva LV, Matrosovich MN, Brenner MK, Bethell RC, Webster RG: Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. Journal of Infectious Diseases. 1998, 178: 1257-1262. 10.1086\/314440.","journal-title":"Journal of Infectious Diseases"},{"key":"1492_CR16","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3201\/eid1504.181280","volume":"15","author":"A Meijer","year":"2009","unstructured":"Meijer A, Lackenby A, Hungnes O, Lina B, van der Werf S, Schweger B, Opp M, Paget J, van de Kassteele J, Hay A, et al: Oseltamivir-resistant influenza virus A (H1N1), Europe 2007-08 Season. Emerging Infectious Diseases. 2009, 15: 552-560. 10.3201\/eid1504.081280.","journal-title":"Emerging Infectious Diseases"},{"key":"1492_CR17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/135965350400900404","volume":"9","author":"Y Abed","year":"2004","unstructured":"Abed Y, Goyette N, Boivin G: A reverse genetics study of resistance to neuraminidase inhibitors in an in?uenzaA(H1N1) virus. Antiviral Therapy. 2004, 9: 577-581.","journal-title":"Antiviral Therapy"},{"key":"1492_CR18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/135965350701200S04.1","volume":"12","author":"FY Aoki","year":"2007","unstructured":"Aoki FY, Boivin G, Roberts N: Influenza virus susceptibility and resistance to oseltamivir. Antiviral Therapy. 2007, 12: 603-616.","journal-title":"Antiviral Therapy"},{"key":"1492_CR19","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/nature06956","volume":"453","author":"PJ Collins","year":"2011","unstructured":"Collins PJ, Haire LF, Lin YP, Liu J, Russel RJ, Walker PA, et al: Crystal structures of oseltamivir-resistant in?uenza virus neuraminidase mutants. Nature. 2011, 453: 1258-1261.","journal-title":"Nature"},{"key":"1492_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.13.05.08026-en","volume":"13","author":"A Lackenby","year":"2008","unstructured":"Lackenby A, Hughes C, Dudman S, Meijer A, Pareek M, Hay A: Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Eurosurveillance. 2008, 13: 1-2.","journal-title":"Eurosurveillance"},{"key":"1492_CR21","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1128\/AAC.46.12.3809-3816.2002","volume":"46","author":"MZ Wang","year":"2002","unstructured":"Wang MZ, Tai CV, Mendel DB: Mechanism by which mutations at His274 alter sensitivity of in?uenza A virus N1 neuraminidase to oseltamivir carboxylate and zanamivir. Antimicrob Agents Chemother. 2002, 46: 3809-3816. 10.1128\/AAC.46.12.3809-3816.2002.","journal-title":"Antimicrob Agents Chemother"},{"key":"1492_CR22","volume-title":"Cochrane Handbook for systematic reviews of interventions, version 5.0.0","author":"JP Higgins","year":"2009","unstructured":"Higgins JP, Green S: Cochrane Handbook for systematic reviews of interventions, version 5.0.0. 2009, John Wiley & Sons"},{"key":"1492_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","volume":"336","author":"L Wood","year":"2008","unstructured":"Wood L, Egger M, Gluud LL, Schulz K, J\u00fcni P, Gluud C, Martin R, Wood A, Sterne JA: Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemioogical study. British Medical Journal. 2008, 336: 601-605. 10.1136\/bmj.39465.451748.AD.","journal-title":"British Medical Journal"},{"key":"1492_CR24","volume-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis","author":"GA Wells","year":"2010","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. 2010, [ http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm ]"},{"key":"1492_CR25","volume-title":"Statistical rules of thumb","author":"G Belle","year":"2002","unstructured":"Belle G: Statistical rules of thumb. 2002, New York: John Wiley & Sons"},{"key":"1492_CR26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/sim.3511","volume":"28","author":"G Rucker","year":"2009","unstructured":"Rucker G, Schwarzer G, Carpenter J, Olkin I: Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells. Statistics in Medicine. 2009, 28: 721-738. 10.1002\/sim.3511.","journal-title":"Statistics in Medicine"},{"key":"1492_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jamda.2005.08.007","volume":"6","author":"A Ambrozaitis","year":"2005","unstructured":"Ambrozaitis A, Gravenstein S, van Essen GA, Rubinstein E, Balciuniene L, Stikleryte A, Crawford C, Elliott M, Shult P: Inhaled zanamivir versus placebo for the prevention of influenza outbreaks in an unvaccinated long-term care population. Journal of the American Medical Directors Association. 2005, 6: 367-374. 10.1016\/j.jamda.2005.08.007.","journal-title":"Journal of the American Medical Directors Association"},{"key":"1492_CR28","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/135965350501000805","volume":"10","author":"L Barosso","year":"2005","unstructured":"Barosso L, Treanor J, Gubareva L, Hayden FG: Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment. Antiviral Therapy. 2005, 10: 901-910.","journal-title":"Antiviral Therapy"},{"key":"1492_CR29","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1086\/315392","volume":"181","author":"G Boivin","year":"2000","unstructured":"Boivin G, Goyette N, Hardy I, Aoki F, Wagner A, Trottier S: Rapid Antiviral Effect of Inhaled Zanamivir in the Treatment of Naturally OccurringInfluenza in Otherwise Healthy Adults. The Journal of Infectious Diseases. 2000, 181: 1471-1474. 10.1086\/315392.","journal-title":"The Journal of Infectious Diseases"},{"key":"1492_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jamda.2005.08.006","volume":"6","author":"S Gravenstein","year":"2005","unstructured":"Gravenstein S, Drinka P, Osterweil D, Schilling M, Krause P, Elliott M, Shult P, Ambrozaitis A, Kandel R, Binder E, et al: Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population. Journal of the American Medical Directors Association. 2005, 6: 359-366. 10.1016\/j.jamda.2005.08.006.","journal-title":"Journal of the American Medical Directors Association"},{"key":"1492_CR31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/135965350000500305","volume":"5","author":"FG Hayden","year":"2000","unstructured":"Hayden FG, Jennings L, Robson R, Schiff G, Jackson H, Rana B, McClelland G, Ipe D, Roberts N, Ward P: Oral oseltamivir in human experimental influenza B infection. Antiviral Therapy. 2000, 5: 205-213.","journal-title":"Antiviral Therapy"},{"key":"1492_CR32","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1056\/NEJM200011023431801","volume":"343","author":"FG Hayden","year":"2000","unstructured":"Hayden FG, Gubareva LV, Monto AS, Klein TC, Elliott MJ, Hammond JM, Sharp SJ, Ossi MJ: Inhaled zanamivir for the prevention of influenza in families. New England Journal of Medicine. 2000, 343: 1282-1289. 10.1056\/NEJM200011023431801.","journal-title":"New England Journal of Medicine"},{"key":"1492_CR33","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1086\/381128","volume":"189","author":"FG Hayden","year":"2004","unstructured":"Hayden FG, Belshe R, Villanueva C, Lanno R, Hughes C, Small I, Dutkowski R, Ward P, Carr J: Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. Journal of Infectious Diseases. 2004, 189: 440-449. 10.1086\/381128.","journal-title":"Journal of Infectious Diseases"},{"key":"1492_CR34","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/00006454-200005000-00005","volume":"19","author":"JA Hedrick","year":"2000","unstructured":"Hedrick JA, Barzilai A, Behre U, Henderson FW, Hammond J, Reilly L, Keene O: Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial. Pediatric Infectious Disease Journal. 2000, 19: 410-417. 10.1097\/00006454-200005000-00005.","journal-title":"Pediatric Infectious Disease Journal"},{"key":"1492_CR35","first-page":"331","volume-title":"American Journal of Transplantation Conference: American Transplant Congress 2009 Boston, MA United States Conference Start: 20090530 Conference End: 20090603 Conference: American Transplant Congress 2009 Boston, MA United States Conference Start: 200","author":"MG Ison","year":"2009","unstructured":"Ison MG, Szakaly P, Shapira MY, Krivn G, Nist A, Dutkowski R: American Journal of Transplantation Conference: American Transplant Congress 2009 Boston, MA United States Conference Start: 20090530 Conference End: 20090603 Conference: American Transplant Congress 2009 Boston, MA United States Conference Start: 200. 2009, 240: 331-"},{"key":"1492_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00006454-200102000-00002","volume":"20","author":"RJ Whitley","year":"2001","unstructured":"Whitley RJ, Hayden F, Reisinger KS, Young N, Dutkowski R, Ipe D, Mills R, Ward P: Oral oseltamivir treatment of influenza in children. Pediatric Infectious Disease Journal. 2001, 20: 127-133. 10.1097\/00006454-200102000-00002.","journal-title":"Pediatric Infectious Disease Journal"},{"key":"1492_CR37","first-page":"823","volume-title":"Pediatric Blood and Cancer Conference: 23rd Annual Meeting of the American Society of Pediatric Hematology\/Oncology, ASPHO 2010 Montreal, QC Canada Conference Start: 20100407 Conference End: 20100410 Conference: 23rd Annual Meeting of the American Soci","author":"C Cost","year":"2010","unstructured":"Cost C, Brock E, Siegel JD, Ardura M: Pediatric Blood and Cancer Conference: 23rd Annual Meeting of the American Society of Pediatric Hematology\/Oncology, ASPHO 2010 Montreal, QC Canada Conference Start: 20100407 Conference End: 20100410 Conference: 23rd Annual Meeting of the American Soci. 2010, 437: 823-"},{"key":"1492_CR38","volume-title":"Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin","author":"H Harvala","year":"2010","unstructured":"Harvala H, Gunson R, Simmonds P, Hardie A, Bennett S, Scott F, Roddie H, McKnight J, Walsh T, Rowney D, et al: The emergence of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December, 2009. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. 2010, 15:"},{"key":"1492_CR39","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1001\/jama.297.13.1435","volume":"297","author":"S Hatakeyama","year":"2007","unstructured":"Hatakeyama S, Sugaya N, Ito M, Yamazaki M, Ichikawa M, Kimura K, Kiso M, Shimizu H, Kawakami C, Koike K, et al: Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA. 2007, 297: 1435-1442. 10.1001\/jama.297.13.1435.","journal-title":"JAMA"},{"key":"1492_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jinf.2007.05.176","volume":"55","author":"N Kawai","year":"2007","unstructured":"Kawai N, Ikematsu H, Iwaki N, Kawashima T, Maeda T, Mitsuoka S, Kondou K, Satoh I, Miyachi K, Yamaga S, et al: Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir. Journal of Infection. 2007, 55: 267-272. 10.1016\/j.jinf.2007.05.176.","journal-title":"Journal of Infection"},{"key":"1492_CR41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1086\/596311","volume":"48","author":"I Stephenson","year":"2009","unstructured":"Stephenson I, Democratis J, Lackenby A, McNally T, Smith J, Pareek M, Ellis J, Bermingham A, Nicholson K, Zambon M: Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. Clinical Infectious Diseases. 2009, 48: 389-396. 10.1086\/596311.","journal-title":"Clinical Infectious Diseases"},{"key":"1492_CR42","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3201\/eid1607.091691","volume":"16","author":"AR Tramontana","year":"2010","unstructured":"Tramontana AR, George B, Hurt AC, Doyle JS, Langan K, Reid AB, Harper JM, Thursky K, Worth LJ, Dwyer DE, et al: Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerging Infectious Diseases. 2010, 16: 1068-1075.","journal-title":"Emerging Infectious Diseases"},{"key":"1492_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.antiviral.2010.04.002","volume":"87","author":"B Wang","year":"2010","unstructured":"Wang B, Dwyer DE, Blyth CC, Soedjono M, Shi H, Kesson A, Ratnamohan M, McPhie K, Cunningham AL, Saksena NK: Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A\/H1N1 09 infections. Antiviral Research. 2010, 87: 16-21. 10.1016\/j.antiviral.2010.04.002.","journal-title":"Antiviral Research"},{"key":"1492_CR44","first-page":"770","volume":"106","author":"R Winzer","year":"2009","unstructured":"Winzer R, Kanig N, Schneitler S, Reuter S, Jensen B, Muller-Stover I, Oh J, Adams O, Mayatepek E, Hengel H, et al: Early clinical experiences with the new influenza A (H1N1\/09). Deutsches Arzteblatt International. 2009, 106: 770-776.","journal-title":"Deutsches Arzteblatt International"},{"key":"1492_CR45","volume-title":"Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin","author":"U Buchholz","year":"2010","unstructured":"Buchholz U, Brockmann S, Duwe S, Schweiger B, an der HM, Reinhardt B, Buda S: Household transmissibility and other characteristics of seasonal oseltamivir-resistant influenza A(H1N1) viruses, Germany, 2007-8. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. 2010, 15:"},{"key":"1492_CR46","volume-title":"Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin","author":"BC Ciancio","year":"2009","unstructured":"Ciancio BC, Meerhoff TJ, Kramarz P, Bonmarin I, Borgen K, Boucher CA, Buchholz U, Buda S, Dijkstra F, Dudman S, et al: Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. 2009, 14:"},{"issue":"2","key":"1492_CR47","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3201\/eid1502.081031","volume":"15","author":"SH Hauge","year":"2009","unstructured":"Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O: Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerging Infectious Diseases. 2009, 15 (2): 155-162. 10.3201\/eid1502.081031. Date of Publication: February 2009 2009, 379 155-162","journal-title":"Emerging Infectious Diseases"},{"key":"1492_CR48","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1001\/jama.2009.294","volume":"301","author":"NJ Dharan","year":"2009","unstructured":"Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, St GK, Epperson S, Brammer L, Klimov AI, et al: Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA. 2009, 301: 1034-1041. 10.1001\/jama.2009.294.","journal-title":"JAMA"},{"key":"1492_CR49","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1056\/NEJMc0910060","volume":"361","author":"M Baz","year":"2009","unstructured":"Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, Boivin G: Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med. 2009, 361: 2296-2297. 10.1056\/NEJMc0910060.","journal-title":"N Engl J Med"},{"key":"1492_CR50","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1086\/508777","volume":"43","author":"M Baz","year":"2006","unstructured":"Baz M, Abed Y, McDonald J, Boivin G: Characterization of multidrug-resistant influenza A\/H3N2 viruses shed during 1 year by an immunocompromised child. Clinical Infectious Diseases. 2006, 43: 1555-1561. 10.1086\/508777.","journal-title":"Clinical Infectious Diseases"},{"key":"1492_CR51","first-page":"478","volume-title":"Nature","author":"QM Le","year":"2005","unstructured":"Le QM, Someya K, Sakati YT: Avian flu: Isolation of drug-resistant H5N1 virus. Nature. 2005, 478-"},{"key":"1492_CR52","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1056\/NEJMoa054512","volume":"353","author":"MD de Jong","year":"2005","unstructured":"de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, et al: Oseltamivir resistance during treatment of influenza A (H5N1) infection. New England Journal of Medicine. 2005, 353: 2667-2672. 10.1056\/NEJMoa054512.","journal-title":"New England Journal of Medicine"},{"key":"1492_CR53","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jcv.2010.03.027","volume":"48","author":"G Campanini","year":"2010","unstructured":"Campanini G, Piralla A, Rovida F, Puzelli S, Facchini M, Locatelli F, Minoli L, Percivalle E, Donatelli I, Baldanti F, et al: First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A\/H1N1v infection. Journal of Clinical Virology. 2010, 48: 220-222. 10.1016\/j.jcv.2010.03.027.","journal-title":"Journal of Clinical Virology"},{"key":"1492_CR54","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/INF.0b013e3181cd7244","volume":"29","author":"A Cane","year":"2010","unstructured":"Cane A, Casanueva E, Iolster T, Sticco N, Richards L, Sosa P, Pontoriero A, Avaro M, Zcech A, Carabajal E, et al: First isolation of a oseltamivir-resistant influenza A (H1N1) strain in Argentina. Pediatric Infectious Disease Journal. 2010, 29: 384-","journal-title":"Pediatric Infectious Disease Journal"},{"key":"1492_CR55","first-page":"893","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","unstructured":"Centers for Disease Control and Prevention (CDC): Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR - Morbidity & Mortality Weekly Report. 2009, 58: 893-896.","journal-title":"MMWR - Morbidity & Mortality Weekly Report"},{"key":"1492_CR56","first-page":"969","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","unstructured":"Centers for Disease Control and Prevention (CDC): Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009. MMWR - Morbidity & Mortality Weekly Report. 2009, 58: 969-972.","journal-title":"MMWR - Morbidity & Mortality Weekly Report"},{"key":"1492_CR57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1750-2659.2010.00144.x","volume":"465","author":"BA Couturier","year":"2010","unstructured":"Couturier BA, Bender JM, Schwarz MA, Pavia AT, Hanson KE, She RC: Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients. Influenza and other Respiratory Viruses. 2010, 465: 199-204. 4 (4) (pp 199-204), 2010 Date of Publication: July 2010","journal-title":"Influenza and other Respiratory Viruses"},{"key":"1492_CR58","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1086\/652655","volume":"50","author":"DE Dulek","year":"2010","unstructured":"Dulek DE, Williams JV, Creech CB, Schulert AK, Frangoul HA, Domm J, Denison MR, Chappell JD: Use of intravenous zanamivir after development of oseltamivir resistance in a critically Ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus. Clinical Infectious Diseases. 2010, 50: 1493-1496. 10.1086\/652655.","journal-title":"Clinical Infectious Diseases"},{"key":"1492_CR59","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1056\/NEJMc0910893","volume":"362","author":"AH Gaur","year":"2010","unstructured":"Gaur AH, Bagga B, Barman S, Hayden R, Lamptey A, Hoffman JM, Bhojwani D, Flynn PM, Tuomanen E, Webby R: Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. New England Journal of Medicine. 2010, 362: 88-89. 10.1056\/NEJMc0910893.","journal-title":"New England Journal of Medicine"},{"key":"1492_CR60","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/INF.0b013e3181cd9524","volume":"29","author":"D Glikman","year":"2010","unstructured":"Glikman D, Zonis Z, Hindiyeh M, Ram D, Mandelboim M, Mendelson E, Engelhard D: Development of oseltamivir resistance during oseltamivir therapy in a child with severe 2009 H1N1 influenza.[Erratum appears in Pediatr Infect Dis J. 2010 May;29(5):478 Note: Hindyieh, Musa [corrected to Hindiyeh, Musa]]. Pediatric Infectious Disease Journal. 2010, 29: 385-386. 10.1097\/INF.0b013e3181cd9524.","journal-title":"Pediatric Infectious Disease Journal"},{"key":"1492_CR61","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3201\/eid1607.091579","volume":"16","author":"GA Hill-Cawthorne","year":"2010","unstructured":"Hill-Cawthorne GA, Schelenz S, Lawes M, Dervisevic S: Oseltamivir-resistant pandemic (H1N1) 2009 in patient with impaired immune system. Emerging Infectious Diseases. 2010, 16: 1185-1186.","journal-title":"Emerging Infectious Diseases"},{"key":"1492_CR62","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1086\/500465","volume":"193","author":"MG Ison","year":"2006","unstructured":"Ison MG, Gubareva LV, Atmar RL, Treanor J, Hayden FG: Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. [Review] [16 refs]. Journal of Infectious Diseases. 2006, 193: 760-764. 10.1086\/500465.","journal-title":"Journal of Infectious Diseases"},{"key":"1492_CR63","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1086\/651610","volume":"201","author":"MJ Memoli","year":"2010","unstructured":"Memoli MJ, Hrabal RJ, Hassantoufighi A, Jagger BW, Sheng ZM, Eichelberger MC, Taubenberger JK: Rapid selection of a transmissible multidrug-resistant influenza A\/H3N2 virus in an immunocompromised host. Journal of Infectious Diseases. 2010, 201: 1397-1403. 10.1086\/651610.","journal-title":"Journal of Infectious Diseases"},{"key":"1492_CR64","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1086\/656439","volume":"51","author":"HT Nguyen","year":"2010","unstructured":"Nguyen HT, Fry AM, Loveless PA, Klimov AI, Gubareva LV: Recovery of a Multidrug-Resistant Strain of Pandemic Influenza A 2009 (H1N1) Virus Carrying a Dual H275Y\/I223R Mutation from a Child after Prolonged Treatment with Oseltamivir. CID. 2010, 51: 983-984. 10.1086\/656439.","journal-title":"CID"},{"key":"1492_CR65","volume-title":"Program and abstracts of the International Society forIn?uenza and other Respiratory Virus Diseases Hong Kong SAR, China: Options forthe Control of Infuenza VII","author":"D Rousset","year":"2010","unstructured":"Rousset D, Goff JL, Abou-Jaoude G, Molina JM, Scelma A, Caro V, Enouf V, Simon F, van der Werf S: Emergence of successive mutations in neuraminidase of the pandemic H1N1 virus respectively associated with oseltamivir resistance and reduced susceptibility to both oseltamivir and zanamivir under treatment with neuraminidase inhibitors [abstract P-198]. Program and abstracts of the International Society forIn?uenza and other Respiratory Virus Diseases Hong Kong SAR, China: Options forthe Control of Infuenza VII. 2010"},{"key":"1492_CR66","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5694\/j.1326-5377.2010.tb03459.x","volume":"192","author":"DJ Speers","year":"2010","unstructured":"Speers DJ, Williams SH, Pinder M, Moody HR, Hurt AC, Smith DW: Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case. Medical Journal of Australia. 2010, 192: 166-168.","journal-title":"Medical Journal of Australia"},{"key":"1492_CR67","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1743-422X-7-88","volume":"7","author":"AA Thabet","year":"2010","unstructured":"Thabet AA, Al-Bahlooli SH, Al-Kohlani A, Shoja'a A: Oseltamivir-resistant pandemic (H1N1)2009 in Yemen - case report. Virology Journal. 2010, 7: 88-10.1186\/1743-422X-7-88.","journal-title":"Virology Journal"},{"key":"1492_CR68","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1056\/NEJMc1003749","volume":"363","author":"E van der Vries","year":"2010","unstructured":"van der Vries E, Stelma FF, Boucher CAB: Emergence of Multidrug-Resistant Pandemic Influenza A (H1N1) Virus. New England Journal of Medicine. 2010, 363: 1381-1382. 10.1056\/NEJMc1003749.","journal-title":"New England Journal of Medicine"},{"key":"1492_CR69","doi-asserted-by":"publisher","first-page":"e1001015","DOI":"10.1371\/journal.ppat.1001015","volume":"6","author":"ME Hamelin","year":"2010","unstructured":"Hamelin ME, Baz M, Abed Y, Couture C, Joubert P, Beaulieu E, Bellerose N, Plante M, Mallett C, Schumer G, et al: Oseltamivir-resistant pandemic A\/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathog. 2010, 6: e1001015-10.1371\/journal.ppat.1001015.","journal-title":"PLoS Pathog"},{"key":"1492_CR70","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1128\/AAC.00474-10","volume":"54","author":"S Kohno","year":"2010","unstructured":"Kohno S, Kida H, Mizuguchi M, Shimada J: Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection. Antimicrob Agents Chemother. 2010, 54: 4568-4574. 10.1128\/AAC.00474-10.","journal-title":"Antimicrob Agents Chemother"},{"key":"1492_CR71","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1099\/vir.0.017459-0","volume":"91","author":"A Boltz","year":"2010","unstructured":"Boltz A, Douangngeun B, Phommachanh P, et al: Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic. Journal of General Virology. 2010, 91: 949-959. 10.1099\/vir.0.017459-0.","journal-title":"Journal of General Virology"},{"key":"1492_CR72","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jiph.2009.04.004","volume":"2","author":"KC Earhart","year":"2009","unstructured":"Earhart KC, Elsayed NM, Saad MD, Gubareva LV, Nayel A, Deyde VM, Abdelsattar A, Abdelghani AS, Boynton BR, Mansour MM, et al: Oseltamivir resistant mutation N249S in human influenza (H5N1) virus in Egypt. Journal of infection and public health. 2009, 2: 74-80. 10.1016\/j.jiph.2009.04.004.","journal-title":"Journal of infection and public health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-11-134\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T22:04:56Z","timestamp":1686089096000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-11-134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,19]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1492"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-11-134","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,19]]},"article-number":"134"}}